Understanding the Molecular Interaction of TDP-43 and Amyloid-β in Alzheimer’s disease
碩士 === 國立臺灣大學 === 生化科技學系 === 107 === ALS disease hallmarks, TDP-43 pathology, were rather common in Alzheimer’s disease (AD), which suggested that TDP-43 might be the third important disease hallmarks in AD besides the well-known AD hallmarks, amyloid-β (Aβ) and tau protein. From the previous result...
Main Authors: | Rong-Shuo Chen, 陳容碩 |
---|---|
Other Authors: | Yun-Ru Chen |
Format: | Others |
Language: | en_US |
Published: |
2019
|
Online Access: | http://ndltd.ncl.edu.tw/handle/25d4v4 |
Similar Items
-
TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer’s disease
by: Yao-Hsiang Shih, et al.
Published: (2020-11-01) -
TDP-43 and amyloid precursor protein processing: implications for Alzheimer’s disease
by: David A Hicks
Published: (2021-01-01) -
TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Wendi Huang, et al.
Published: (2020-02-01) -
TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
by: Stephani A. Davis, et al.
Published: (2017-07-01) -
Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
by: Sandra O. Tomé, et al.
Published: (2020-04-01)